Clinical Trial

A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 2, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This clinical trial aims to assess the impact on exercise tolerance and the safety of inhaled nitric oxide in subjects with moderate-to-severe COPD. The findings are expected to contribute to the development of safe and effective therapeutic strategies for COPD management.
Trial Details
NCT Number NCT07382258
Lead Sponsor Novlead Inc.
Collaborators: The First Affiliated Hospital with Nanjing Medical University
Conditions Chronic Obstructive Pulmonary Disease (COPD)
Enrollment 16 participants
Start Date 2023-05-17
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-02